89bio Inc (ETNB)

7.34 -0.06 (-0.81%) USD  |  NASDAQ  |  Jan 08, 12:32
More

89bio Research and Development Expense (Annual): 122.23M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ETNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Madrigal Pharmaceuticals Inc 272.35M
Eli Lilly and Co 9.313B
Viking Therapeutics Inc 63.81M
Akero Therapeutics Inc 141.80M
NovaBay Pharmaceuticals Inc 0.068M